Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice
Open accessAbstract
Although previous research has demonstrated a role for kappa opioid receptor-mediated signaling in escalated alcohol consumption associated with dependence and stress exposure, involvement of the dynorphin/kappa opioid receptor (DYN/KOR) system in binge-like drinking has not been fully explored. Here we used pharmacological and chemogenetic approaches to examine the influence of DYN/KOR signaling on alcohol consumption in the drinking-in-the-dark (DID) model of binge-like drinking. Systemic administration of the KOR agonist U50,488 increased binge-like drinking (Experiment 1) while, conversely, systemic administration of the KOR antagonist nor-BNI reduced drinking in the DID model (Experiment 2). These effects of systemic KOR manipulation were selective for alcohol as neither drug influenced consumption of sucrose in the DID paradigm (Experiment 3). In Experiment 4, administration of the long-acting KOR antagonist nor-BNI into the central nucleus of the amygdala (CeA) decreased alcohol intake. Next, targeted "silencing" of DYN+ neurons in the CeA was accomplished using a chemogenetic strategy. Cre-dependent viral expression in DYN+ neurons was confirmed in CeA of Pdyn-IRES-Cre mice and functionality of an inhibitory (hM4Di) DREADD was validated (Experiment 5). Activating the inhibitory DREADD by CNO injection reduced binge-like alcohol drinking, but CNO injection did not alter alcohol intake in mice that were treated with control virus (Experiment 6). Collectively, these results demonstrate that DYN/KOR signaling in the CeA contributes to excessive alcohol consumption in a binge-drinking model.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(2023) · doi:10.1126/science · Cited by 6,063 · see citing works
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698 · see citing works
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046 · see citing works
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Gomez, J. L., Bonaventura, J., Lesniak, W., Mathews, W. B., Sysa-Shah, P., Rodriguez, L. A., Ellis, R. J., Richie, C. T., Harvey, B. K., Dannals, R. F., et al. (2017) · Science · doi:10.1126/science.aan2475 · Cited by 980 · see citing works
Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice
Rhodes, J. S., Best, K., Belknap, J. K., Finn, D. A., & Crabbe, J. C. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.10.007 · Cited by 820 · see citing works
An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., Vong, L., Pei, H., Watabe-Uchida, M., Uchida, N., et al. (2014) · Nature · doi:10.1038/nature12956 · Cited by 603 · see citing works
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544 · see citing works
The Central Amygdala as an Integrative Hub for Anxiety and Alcohol Use Disorders
Gilpin, N. W., Herman, M. A., & Roberto, M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.008 · Cited by 457 · see citing works
Jennison, K. M. (2004) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-200032331 · Cited by 401 · see citing works
The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398 · see citing works
Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence
Walker, B. M., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301438 · Cited by 392 · see citing works
Manvich, D. F., Webster, K. A., Foster, S. L., Farrell, M. S., Ritchie, J., Porter, J. H., & Weinshenker, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-22116-z · Cited by 367 · see citing works
Mouse inbred strain differences in ethanol drinking to intoxication
Rhodes, J. S., Ford, M. M., Yu, C. ‐., Brown, L. L., Finn, D. A., Garland, T., & Crabbe, J. C. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00210.x · Cited by 340 · see citing works
Roberto, M., Cruz, M. T., Gilpin, N. W., Sabino, V., Schweitzer, P., Bajo, M., Cottone, P., Madamba, S. G., Stouffer, D. G., Zorrilla, E. P., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.007 · Cited by 336 · see citing works
Thiele, T. E., & Navarro, M. (2013) · Alcohol · doi:10.1016/j.alcohol.2013.08.005 · Cited by 268 · see citing works
Neurocircuitry of alcohol addiction
Koob, G. F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 227 · see citing works
Preclinical studies of alcohol binge drinking
Crabbe, J. C., Harris, R. A., & Koob, G. F. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05895.x · Cited by 221 · see citing works
Walker, B. M., Zorrilla, E. P., & Koob, G. F. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00226.x · Cited by 202 · see citing works
NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking
Pleil, K. E., Rinker, J. A., Lowery-Gionta, E. G., Mazzone, C. M., McCall, N. M., Kendra, A. M., Olson, D. P., Lowell, B. B., Grant, K. A., Thiele, T. E., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3972 · Cited by 195 · see citing works
Self-citationContinuity of Binge and Harmful Drinking From Late Adolescence to Early Adulthood
McCarty, C. A., Ebel, B. E., Garrison, M. M., DiGiuseppe, D. L., Christakis, D., & Rivara, F. P. (2004) · PEDIATRICS · doi:10.1542/peds.2003-0864-l · Cited by 180 · see citing works
Involvement of dynorphin and the kappa opioid receptor in feeding
Morley, J. E., & Levine, A. S. (1983) · Peptides · doi:10.1016/0196-9781(83)90069-4 · Cited by 172 · see citing works
Crabbe, J. C., Metten, P., Rhodes, J. S., Yu, C.-H., Brown, L. L., Phillips, T. J., & Finn, D. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.002 · Cited by 163 · see citing works
κ1 Receptor mRNA Distribution in the Rat CNS: Comparison to κ Receptor Binding and Prodynorphin mRNA
Mansour, A., Fox, C. A., Meng, F., Akil, H., & Watson, S. J. (1994) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1994.1015 · Cited by 154 · see citing works
Lowery-Gionta, E. G., Navarro, M., Li, C., Pleil, K. E., Rinker, J. A., Cox, B. R., Sprow, G. M., Kash, T. L., & Thiele, T. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6256-11.2012 · Cited by 149 · see citing works
Self-citationThe one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors
Kissler, J. L., Sirohi, S., Reis, D. J., Jansen, H. T., Quock, R. M., Smith, D. G., & Walker, B. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.014 · Cited by 145 · see citing works
“Drinking in the Dark” (DID): A Simple Mouse Model of Binge‐Like Alcohol Intake
Thiele, T. E., Crabbe, J. C., & Boehm, S. L. (2014) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0949s68 · Cited by 140 · see citing works
Li, C., Pleil, K. E., Stamatakis, A. M., Busan, S., Vong, L., Lowell, B. B., Stuber, G. D., & Kash, T. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.015 · Cited by 139 · see citing works
Self-citationLowery, E. G., Spanos, M., Navarro, M., Lyons, A. M., Hodge, C. W., & Thiele, T. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.209 · Cited by 137 · see citing works
Rose, J. H., Karkhanis, A. N., Chen, R., Gioia, D., Lopez, M. F., Becker, H. C., McCool, B. A., & Jones, S. R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv127 · Cited by 136 · see citing works
Self-citationSex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
Chartoff, E. H., & Mavrikaki, M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00466 · Cited by 134 · see citing works
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment
Crowley, N. A., & Kash, T. L. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.001 · Cited by 132 · see citing works
Self-citationStamatakis, A. M., Sparta, D. R., Jennings, J. H., McElligott, Z. A., Decot, H., & Stuber, G. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.046 · Cited by 132 · see citing works
Karkhanis, A. N., Rose, J. H., Weiner, J. L., & Jones, S. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.21 · Cited by 131 · see citing works
Rinker, J. A., Marshall, S. A., Mazzone, C. M., Lowery‐Gionta, E. G., Gulati, V., Pleil, K. E., Kash, T. L., Navarro, M., & Thiele, T. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.029 · Cited by 130 · see citing works
Self-citationSperling, R. E., Gomes, S. M., Sypek, E. I., Carey, A. N., & McLaughlin, J. P. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1844-5 · Cited by 127 · see citing works
Marchant, N. J., Densmore, V. S., & Osborne, P. B. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21464 · Cited by 123 · see citing works
Melief, E. J., Miyatake, M., Carroll, F. I., Béguin, C., Carlezon, W. A., Cohen, B. M., Grimwood, S., Mitch, C. H., Rorick‐Kehn, L. M., & Chavkin, C. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074195 · Cited by 105 · see citing works
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety
Schank, J. R., Goldstein, A., Rowe, K. E., King, C. E., Marusich, J. A., Wiley, J. L., Carroll, F. I., Thorsell, A., & Heilig, M. A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00455.x · Cited by 101 · see citing works
Russell, S. E., Rachlin, A. B., Smith, K. L., Muschamp, J. W., Berry, L., Zhao, Z., & Chartoff, E. H. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.042 · Cited by 101 · see citing works
Anderson, R. I., Becker, H. C., Adams, B. L., Jesudason, C. D., & Rorick‐Kehn, L. M. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00033 · Cited by 98 · see citing works
Self-citationDynorphin–Still an Extraordinarily Potent Opioid Peptide
Chavkin, C. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083337 · Cited by 94 · see citing works
The neurobiology of binge-like ethanol drinking: Evidence from rodent models
Sprow, G. M., & Thiele, T. E. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.12.026 · Cited by 94 · see citing works
Oxytocin reduces ethanol self-administration in mice
King, C. E., Griffin, W. C., Luderman, L. N., Kates, M. M., McGinty, J. F., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13359 · Cited by 89 · see citing works
Self-citationBeczkowska, I. W., Bowen, W. D., & Bodnar, R. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91289-q · Cited by 88 · see citing works
Mitch, C. H., Quimby, S. J., Diaz, N., Pedregal, C., de la Torre, M. G., Jiménez, A., Shi, Q., Canada, E. J., Kahl, S. D., Statnick, M. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200789r · Cited by 88 · see citing works
Lam, M. P., Marinelli, P. W., Bai, L., & Gianoulakis, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1267-8 · Cited by 86 · see citing works
Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol
Anderson, R. I., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13406 · Cited by 79 · see citing works
Self-citationSparrow, A. M., Lowery‐Gionta, E. G., Pleil, K. E., Li, C., Sprow, G. M., Cox, B. R., Rinker, J. A., Jijon, A. M., Peňa, J., Navarro, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.327 · Cited by 73 · see citing works
Self-citationDomi, E., Barbier, E., Augier, E., Augier, G., Gehlert, D. R., Barchiesi, R., Thorsell, A., Holm, L., & Heilig, M. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0015-y · Cited by 73 · see citing works
Anderson, R. I., Lopez, M. F., & Becker, H. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00045 · Cited by 69 · see citing works
Self-citationRobles, C. F., McMackin, M. Z., Campi, K. L., Doig, I. E., Takahashi, E. Y., Pride, M. C., & Trainor, B. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.003 · Cited by 65 · see citing works
Olney, J. J., Navarro, M., & Thiele, T. E. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12591 · Cited by 64 · see citing works
Berger, A. L., Williams, A. M., McGinnis, M. M., & Walker, B. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.229 · Cited by 62 · see citing works
κ-Opioid Receptors in the Central Amygdala Regulate Ethanol Actions at Presynaptic GABAergic Sites
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202903 · Cited by 54 · see citing works
Kissler, J. L., & Walker, B. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.183 · Cited by 43 · see citing works
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225870 · Cited by 37 · see citing works
Long-term ethanol effects on acute stress responses: modulation by dynorphin
Rácz, I., Markert, A., Mauer, D., Stoffel‐Wagner, B., & Zimmer, A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00494.x · Cited by 36 · see citing works
Zhou, Y., Crowley, R. S., Ben, K. T., Prisinzano, T. E., & Kreek, M. J. (2017) · Brain Research · doi:10.1016/j.brainres.2017.02.027 · Cited by 21 · see citing works
Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol
Anderson, R. I., Moorman, D. E., & Becker, H. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_100 · Cited by 18 · see citing works
Self-citationKappa‐opioid receptors differentially regulate low and high levels of ethanol intake in female mice
Veer, A. V., Smith, K. L., Cohen, B. M., Carlezon, W. A., & Bechtholt, A. J. (2016) · Brain and Behavior · doi:10.1002/brb3.523 · Cited by 14 · see citing works
Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [2]2. NIAAA NIoAAaA. National Institute on Alcohol Abuse and Alcoholism Council approves definition of binge drinking. NIAAA Newsl. 2004;3:3.
Cited by
Sorted by citations
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337 · see citing works
Alcohol and the brain: from genes to circuits
Egervári, G., Siciliano, C. A., Whiteley, E. L., & Dorit Ron, A. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.09.006 · Cited by 117 · see citing works
Torruella-Suárez, M. L., Vandenberg, J. R., Cogan, E. S., Tipton, G. J., Teklezghi, A. T., Dange, K., Patel, G., McHenry, J. A., Hardaway, J. A., Kantak, P. A., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1466-19.2019 · Cited by 83 · see citing works
Kappa opioid receptor and dynorphin signaling in the central amygdala regulates alcohol intake
Bloodgood, D. W., Hardaway, J. A., Stanhope, C. M., Pati, D., Pina, M. M., Neira, S., Desai, S., Boyt, K. M., Palmiter, R. D., & Kash, T. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0690-z · Cited by 71 · see citing works
Self-citationCircuit selectivity in drug versus natural reward seeking behaviors
Nall, R. W., Heinsbroek, J. A., Nentwig, T. B., Kalivas, P. W., & Bobadilla, A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15297 · Cited by 59 · see citing works
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Calleja‐Conde, J., Morales-Garcia, J. A., Echeverry‐Alzate, V., Bühler, K., Giné, E., & López‐Moreno, J. A. (2022) · Addiction Biology · doi:10.1111/adb.13229 · Cited by 54 · see citing works
Dynorphin and its role in alcohol use disorder
Karkhanis, A. N., & Al-Hasani, R. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146742 · Cited by 47 · see citing works
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 44 · see citing works
Nentwig, T. B., Obray, J. D., Vaughan, D. T., & Chandler, L. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-10668-0 · Cited by 41 · see citing works
Walker, L. C. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15301 · Cited by 37 · see citing works
Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders
Song, J., Patel, R. V., Sharif, M. S., Ashokan, A., & Michaelides, M. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.019 · Cited by 33 · see citing works
Haun, H. L., Lebonville, C. L., Solomon, M. G., Griffin, W. C., Lopez, M. F., & Becker, H. C. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.01.002 · Cited by 33 · see citing works
Self-citationLimoges, A., Yarur, H. E., & Tejeda, H. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.963691 · Cited by 33 · see citing works
KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway
Estave, P. M., Spodnick, M. B., & Karkhanis, A. N. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_421 · Cited by 30 · see citing works
Haun, H. L., Griffin, W. C., Lopez, M. F., & Becker, H. C. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107984 · Cited by 30 · see citing works
Self-citationTranscriptomics reveals amygdala neuron regulation by fasting and ghrelin thereby promoting feeding
Peters, C., He, S., Fermani, F., Lim, H., Ding, W., Mayer, C., & Klein, R. (2023) · Science Advances · doi:10.1126/sciadv.adf6521 · Cited by 29 · see citing works
Baird, M. A., Hsu, T. Y., Wang, R., Juarez, B., & Zweifel, L. S. (2020) · eNeuro · doi:10.1523/eneuro.0370-20.2020 · Cited by 28 · see citing works
Novel medications for problematic alcohol use
Heilig, M. A., Witkiewitz, K. A., Ray, L. A., & Leggio, L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172889 · Cited by 27 · see citing works
Herman, M. A., & Quadir, S. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00170-5 · Cited by 26 · see citing works
Borrego, M. B., Grigsby, K. B., Townsley, K. G., Chan, A. E., Firsick, E. J., Tran, A., Savarese, A. M., & Ozburn, A. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108874 · Cited by 24 · see citing works
NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice
Brunori, G., Weger, M., Schoch, J., Targowska‐Duda, K. M., Barnes, M., Borruto, A. M., Rorick‐Kehn, L. M., Zaveri, N. T., Pintar, J. E., Ciccocioppo, R., et al. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14165 · Cited by 21 · see citing works
King, C. E., Griffin, W. C., Lopez, M. F., & Becker, H. C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01046-x · Cited by 21 · see citing works
Self-citationMechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Cameron, C. M., Nieto, S. J., Bosler, L., Wong, M. H., Bishop, I., Mooney, L. J., & Cahill, C. M. (2021) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2021.10009 · Cited by 20 · see citing works
Lorente, J. D., Cuitavi, J., Campos‐Jurado, Y., Montón-Molina, R., González-Romero, J. L., & Hipólito, L. (2021) · Pain · doi:10.1097/j.pain.0000000000002332 · Cited by 19 · see citing works
Neuropeptides and Neurotransmission
Gantait, A. M., Bataineh, Y. A., Surchi, H. S., Gantait, A., Rani, G. T., Paul, P., Kokaz, S. F., Al-Jaidi, B. A., Kumar, P., Karan, S., et al. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_16 · Cited by 18 · see citing works
Differential regulation of alcohol consumption and reward by the transcriptional cofactor LMO4
Maiya, R., Pomrenze, M. B., Tran, T. N. A., Tiwari, G. R., Beckham, A., Paul, M. T., Mayfield, R. D., & Messing, R. O. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0706-8 · Cited by 17 · see citing works
Heilig, M. A. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13636 · Cited by 17 · see citing works
Bauer, M. R., McVey, M. M., Germano, D. M., Zhang, Y., & Boehm, S. L. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113631 · Cited by 13 · see citing works
The Dynorphin/-Opioid Receptor System at the Interface of Hyperalgesia/Hyperkatifeia and Addiction
Marchette, R. C. N., Vendruscolo, L. F., & Koob, G. F. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00618-x · Cited by 13 · see citing works
Pich, E. M., Tarnanas, I., Brigidi, P., & Collo, G. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100713 · Cited by 13 · see citing works
Pirino, B. E., Kelley, A. M., Karkhanis, A. N., & Barson, J. R. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15078 · Cited by 13 · see citing works
Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain
Lee, G. J., Kim, S. A., Kim, Y. J., & Oh, S. B. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147445 · Cited by 12 · see citing works
Özkan-Kotiloğlu, S., Kaya-Akyüzlü, D., Yurdakul, R., Yıldırım, M. A., & İlhan, İ. Ö. (2023) · Alcohol and Alcoholism · doi:10.1093/alcalc/agad036 · Cited by 12 · see citing works
Regulation of alcohol drinking by ventral striatum and extended amygdala circuitry
Borrego, M. B., Chan, A. E., & Ozburn, A. R. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109074 · Cited by 11 · see citing works
Khom, S., Nguyen, J. D., Vandewater, S. A., Grant, Y., Roberto, M., & Taffe, M. A. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.780500 · Cited by 10 · see citing works
Pina, M. M., Pati, D., Neira, S., Taxier, L. R., Stanhope, C. M., Mahoney, A. A., D’Ambrosio, S., Kash, T. L., & Navarro, M. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0406-22.2023 · Cited by 10 · see citing works
Self-citationPirino, B. E., Hawks, A., Carpenter, B. A., Candelas, P. G., Gargiulo, A. T., Curtis, G. R., Karkhanis, A. N., & Barson, J. R. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01850-1 · Cited by 10 · see citing works
Subregional Differences in Alcohol Modulation of Central Amygdala Neurocircuitry
Melkumyan, M., & Silberman, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.888345 · Cited by 9 · see citing works
Acute and chronic alcohol modulation of extended amygdala calcium dynamics
Roland, A. V., Chao, T.-H. H., Hon, O. J., Machinski, S. N., Sides, T. R., Lee, S. I., Shih, Y. I., & Kash, T. L. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.02.004 · Cited by 9 · see citing works
Self-citationTabbara, R. I., Rahbarnia, A., Lê, A. D., & Fletcher, P. J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05647-0 · Cited by 9 · see citing works
Emerging medications and pharmacological treatment approaches for substance use disorders
Raymond, J. S., Athanasopoulos, A. G., Badolato, C. J., Doolan, T. M., Scicluna, R. L., Everett, N. A., Bowen, M. T., & James, M. H. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173952 · Cited by 8 · see citing works
Leveraging Neural Networks in Preclinical Alcohol Research
Smith, L. C., & Kimbrough, A. (2020) · Brain Sciences · doi:10.3390/brainsci10090578 · Cited by 8 · see citing works
Nelson, C. A., Brundage, J., Williams, B. M., Baldridge, J., Stockard, A. L., Bassett, C. H., Burger, B. J., Gunter, B. T., Payne, A. J., Yorgason, J. T., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071593 · Cited by 6 · see citing works
Kappa-opioid receptor activation reinstates nicotine self-administration in mice
Gowrishankar, R., Gomez, A. M., Walicki, M. C., & Bruchas, M. R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100017 · Cited by 6 · see citing works
Méndez, H. G., Neira, S., Flanigan, M. E., Haun, H. L., Boyt, K. M., Thiele, T. E., & Kash, T. L. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.06.005 · Cited by 5 · see citing works
Self-citationActivation of the dorsal septum increases alcohol consumption in male C57BL/6J mice
Haun, H. L., D’Ambrosio, S., Pati, D., Taxier, L. R., & Kash, T. L. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100023 · Cited by 5 · see citing works
Self-citationDiastereoselective synthesis of conformationally restricted KOR agonists
Ilari, D., Maskri, S., Schepmann, D., Köhler, J., Daniliuc, C. G., Koch, O., & Wünsch, B. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00398d · Cited by 5 · see citing works
The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Sureshkumar, K., Go, J., Tran, M., Malhotra, S., Ahmad, S. M., & Lutfy, K. (2022) · Psychoactives · doi:10.3390/psychoactives1020006 · Cited by 5 · see citing works
Grigsby, K. B., Kerr, N. R., Kelty, T. J., Mao, X., Childs, T. E., & Booth, F. W. (2022) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk8010006 · Cited by 5 · see citing works
Schrank, S., Sevigny, J. P., Yunus, N. I., Vetter, K., Aguilar, O. D., Ily, V., Valchinova, M., Keinath, A. T., & Sparta, D. R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110174 · Cited by 4 · see citing works
Nosova, O., Bazov, I., Karpyak, V. M., Hallberg, M., & Bakalkin, G. Y. (2021) · Molecules · doi:10.3390/molecules26113458 · Cited by 4 · see citing works
Torruella-Suárez, M. L., Vandenberg, J. R., Cogan, E. S., Tipton, G. J., Teklezghi, A., Dange, K., Patel, G. K., McHenry, J. A., Hardaway, J. A., Kantak, P. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/245274 · Cited by 4 · see citing works
Lebonville, C. L., Rinker, J. A., O’Hara, K., McMahan, C. S., Hoffman, M., Becker, H. C., & Mulholland, P. J. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111445 · Cited by 3 · see citing works
Self-citationImaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography
Placzek, M. S. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_498 · Cited by 3 · see citing works
Acute and chronic alcohol modulation of extended amygdala calcium dynamicsPreprint
Roland, A. V., Chao, T.-H. H., Hon, O. J., Machinski, S. N., Sides, T. R., Lee, S. I., Shih, Y. I., & Kash, T. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.10.561741 · Cited by 2 · see citing works
Self-citationKappa opioid receptor antagonism in neuropsychiatry: from molecular mechanisms to clinical prospects
Wang, H., Ji, Y., Huang, J., Yang, S., Zhang, Q., Hu, S., Xu, X., & Yang, C. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02216-y · Cited by 1 · see citing works
Dankert, A. M., Kash, T. L., & Thiele, T. E. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15536 · Cited by 1 · see citing works
Self-citation(2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816793-9.00001-3
Nava-Gomez, L. J., & González-González, J. C. (2022) · Revista Iberoamericana ConCiencia. · doi:10.32654/concienciaepg/eds.especial-9
Conway, S. M., & Al‐Hasani, R. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.005
BLA KOR inputs to the BNST regulate social stress-escalated alcohol consumptionPreprint
Paliarin, F., Duplantis, C., Doré, E., Basavanhalli, S., Weiser, E., Jones, T. W., & Maiya, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.07.622470
Lee, S., Romero, L. M., Lammons, J. W., Klein, J. M., Edwards, K. N., Guidry, J. J., & Edwards, S. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110728
George, B. E., Vidrascu, E., Neira, S., Devine, M. P., & Kash, T. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702832
Self-citationHolmes, D., Lopez, M. F., Becker, H. C., Cowan, C. W., & Anderson, E. M. (2026) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70277
Self-citationNogueira, D. D. S. (2019) · theses.fr (ABES) · doi:10.70675/d429d5dbz5001z4e60z9622z4f636e667f17
Albrechet‐Souza, L., & Wills, T. A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111760
- Authors
- Anderson, R. I., Lopez, M. F., Griffin, W. C., Haun, H. L., Bloodgood, D. W., Pati, D., Boyt, K. M., Kash, T. L., & Becker, H. C.
- Affiliations
- Medical University of South Carolina (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Becker, Howard C.
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2018-12-11
- Volume
- 44
- Issue
- 6
- Pages
- 1084-1092
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC6461883
- OpenAlex
- W2903920169
- Cited by
- 68
- References
- 60
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 12 · 2021: 17 · 2020: 10 · 2019: 3 · 2018: 1
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (F32 AA023700, T32 AA007474, P50 AA10716, U01 AA014095, F31 AA025835, P60 AA011605, U24 AA025475)
- U.S. Department of Veterans Affairs (BX 000813)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- dynorphin, kappa opioid receptor, central amygdala, U50,488, nor-binaltorphimine, chemogenetic silencing, DREADD, alcoholism, stress exposure
- MeSH terms
- Animals, Behavior, Animal, Disease Models, Animal, Dynorphins, Genetic Techniques, Male, Mice, Inbred C57BL, Naltrexone, Receptors, Opioid, kappa, 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer, Mice, Binge Drinking, Central Amygdaloid Nucleus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review